Comments
Loading...

Virax Biolabs Group (VRAX) Stock Price, Quote, News & History

VRAXNASDAQ
Logo brought to you by Benzinga Data
$0.2713
0.0083.04%
Last update: Jan 26, 1:40 PM
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open
$0.28
Close
-
Volume / Avg.
201.52K / 5.13M
Day Range
$0.27 - $0.28
52 Wk Range
0.26 - 2.29
Market Cap
$2.01M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
36
Short Interest
1.37%
Days to Cover
1

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-5.41M
Investing Cash Flow (TTM)
-497.40K
Financing Cash Flow (TTM)
1.96M
Free Cash Flow (TTM)
-5.90M
Capital Expenditure (TTM)
-497.40K
Net Change in Cash (TTM)
-3.94M

Analyst Trends and Forecast

1
Jan
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$852.88K
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
402.10
PB Ratio (TTM)
0.37
Earnings Yield % (TTM)
-463.35%
Earnings Yield % (FWD)
-91.15%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.72

Company Debt

Total Debt
$195.58K
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$108.59K
Total Cash
$3.35M
Debt to Equity
0.10
Issuance of Debt (TTM)
-$108.59K
Repayment of Debt (TTM)
-$108.59K

Key Statistics

Open
$0.28
Close
-
Volume / Avg.
201.52K / 5.13M
Day Range
$0.27 - $0.28
52 Wk Range
0.26 - 2.29
Market Cap
$2.01M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
36
Short Interest
1.37%
Days to Cover
1

About

Sector
Health Care
Industry
Health Care Providers & Services
Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and service...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
VRAX
AHG

FAQ

Q

How do I buy Virax Biolabs Group (VRAX) stock?

A

You can purchase shares of Virax Biolabs Group (NASDAQ:VRAX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Virax Biolabs Group (VRAX) competitors?

Q

What is the forecast, or price target, for Virax Biolabs Group (VRAX) stock?

A

Virax Biolabs Group has a consensus price target of $1.00.

Q

What is the current price for Virax Biolabs Group (VRAX)?

A

The stock price for Virax Biolabs Group (NASDAQ: VRAX) is $0.2713 last updated January 26, 2026 at 1:40 PM EST.

Q

Does Virax Biolabs Group (VRAX) pay a dividend?

A

There are no upcoming dividends for Virax Biolabs Group.

Q

When is Virax Biolabs Group (NASDAQ:VRAX) reporting earnings?

A

Virax Biolabs Group does not have any upcoming earnings scheduled.

Q

Is Virax Biolabs Group (VRAX) going to split?

A

There is no upcoming split for Virax Biolabs Group.

Q

What sector and industry does Virax Biolabs Group (VRAX) operate in?

A

Virax Biolabs Group is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.